201 COLLEGE RD E PRINCETON, NJ 08540 Get Directions
201 COLLEGE RD E PRINCETON, NJ 08540 Get Directions
Welcome to the New Laureate Biopharma
With more than 30 years of therapeutic protein development and supply experience, Laureate Biopharma is recapitalized and revitalized. We have a more robust portfolio of services and are well-positioned to provide tailored solutions to meet your needs.
Trust Laureate Biopharma as your CMO. Collaborate with our experts as they evaluate cGMP conditions and ensure on-time delivery to make the most of your biopharmaceutical development program, everytime.
About Laureate
Laureate Biopharma is a leader in biopharmaceutical contract development and manufacturing. Our scientists are expert in process development and cGMP production of therapeutic proteins, including monoclonal antibodies and Fc-fusion proteins. In addition, our portfolio of services includes aseptic filling, cell line development, analytical and stability testing, and regulatory support. Laureate has served a global client base from its Princeton, New Jersey facility since 1981.
Welcome to Gallus - Contract Manufacturer of Mammalian Cell Biologics
Gallus is a mammalian cell culture contract manufacturing organization (CMO) that offers a unique level of flexibility and strategic appeal to companies seeking to develop and manufacture biologics. As a pure-play CMO, we deliver a high level of quality and reliability to our clinical and commercial clients. With the recent acquisition of Laureate BioPharmaceuticals we have strengthened our capabilities with increased service offerings and capacity in our combined locations of St. Louis, Missouri and Princeton, New Jersey.
In addition to a stellar commercial manufacturing history the new Gallus offers clinical fill-finish, a pilot facility and expanded analytics including mass spectrophotometry. Our expanded team of 350 dedicated professionals has a combined experience of nearly 60 decades of biologics manufacturing experience, with an exceptional focus on quality evidenced in a high frequency of tech transfers and a long-term stellar regulatory record. We provide value for your molecule in our uniquely flexible services and business models, including utilizing advanced technologies to improve upstream and downstream processes, reduce project timelines and optimize yields.
With the acquisition, Gallus has significantly expanded our process development laboratories and clinical services suites using single-use technologies, stainless steel and flexible stainless steel and have built our talent pool with industry-recognized expertise in cell culture, purification, analytical development and project management. Combined, Gallus' team and facilities provide the exceptional service you seek for developing and manufacturing the biologic therapies of the future.
The Gallus team is ready to demonstrate our flexibility and how far we'll go to work for you.
© Dun & Bradstreet, Inc. 2024. All rights reserved.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.